• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柠檬酸盐和尿液对草酸钙晶体聚集的影响。

The effects of citrate and urine on calcium oxalate crystal aggregation.

作者信息

Tiselius H G, Fornander A M, Nilsson M A

机构信息

Department of Urology, University Hospital, Linköping, Sweden.

出版信息

Urol Res. 1993;21(5):363-6. doi: 10.1007/BF00296838.

DOI:10.1007/BF00296838
PMID:8279094
Abstract

The rate of crystal sedimentation in a suspension of calcium oxalate monohydrate (COM) crystals was determined spectrophotometrically in the presence and absence of dialysed urine and citrate. A reduced rate of crystal sedimentation after stirring was recorded in suspensions containing citrate in concentrations between 0.33 and 1.67 mmol/l. The sedimentation rate was reduced in the presence of a 0.3-3.3% concentration of dialysed urine, with increased inhibition of crystal sedimentation when the concentration of urine was increased. A comparison of the inhibition of COM crystal sedimentation in whole urine and in dialysed urine from normal subjects and stone-formers disclosed significantly higher values (P < 0.05) in the dialysed urine. The results support previous observations that physiological concentrations of citrate might efficiently inhibit the aggregation of COM crystals. Furthermore even low concentrations of both whole urine and dialysed urine are apparently very efficient inhibitors of COM crystal aggregation.

摘要

在有无透析尿液和柠檬酸盐存在的情况下,通过分光光度法测定了一水合草酸钙(COM)晶体悬浮液中的晶体沉降速率。在含有浓度为0.33至1.67 mmol/l柠檬酸盐的悬浮液中,搅拌后记录到晶体沉降速率降低。当透析尿液浓度为0.3 - 3.3%时,沉降速率降低,且随着尿液浓度增加,晶体沉降的抑制作用增强。对正常人和结石形成者的全尿和透析尿中COM晶体沉降抑制情况的比较显示,透析尿中的抑制值显著更高(P < 0.05)。这些结果支持了先前的观察结果,即生理浓度的柠檬酸盐可能有效抑制COM晶体的聚集。此外,即使是低浓度的全尿和透析尿显然也是COM晶体聚集的非常有效的抑制剂。

相似文献

1
The effects of citrate and urine on calcium oxalate crystal aggregation.柠檬酸盐和尿液对草酸钙晶体聚集的影响。
Urol Res. 1993;21(5):363-6. doi: 10.1007/BF00296838.
2
Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?在高浓度尿液中,柠檬酸盐是草酸钙晶体生长的抑制剂吗?
Urol Res. 1996;24(2):67-71. doi: 10.1007/BF00431081.
3
Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.镁、柠檬酸盐、柠檬酸镁和碱式柠檬酸镁作为尿液中草酸钙结晶的调节剂:对复发性特发性钙尿路结石患者的观察
Urol Res. 1999 Apr;27(2):117-26. doi: 10.1007/s002400050097.
4
Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.23-kD 一水合草酸钙结合蛋白在草酸应激期间对草酸钙结石形成的调节作用
Nephron Physiol. 2004;97(1):p23-30. doi: 10.1159/000077599.
5
Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?尿液中的柠檬酸或柠檬酸盐:在预防草酸钙晶体和结石方面我们应关注哪一个?
Urol Res. 2002 Oct;30(5):336-41. doi: 10.1007/s00240-002-0272-3. Epub 2002 Aug 30.
6
Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.复发性结石形成者中存在晶体过度聚集且柠檬酸盐排泄量低的情况。
Lancet. 1986 May 10;1(8489):1056-8. doi: 10.1016/s0140-6736(86)91329-2.
7
Effects of citrate on the different phases of calcium oxalate crystallization.柠檬酸盐对草酸钙结晶不同阶段的影响。
Scanning Microsc. 1993 Mar;7(1):381-9; discussion 389-90.
8
The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.尿液、焦磷酸盐、柠檬酸盐、镁及糖胺聚糖对草酸钙晶体体外生长和聚集的影响。
Clin Chim Acta. 1981 May;112(3):349-56. doi: 10.1016/0009-8981(81)90458-7.
9
Effects of urinary macromolecules on the crystallization of calcium oxalate.尿大分子对草酸钙结晶的影响。
Urol Res. 1990;18(6):381-5. doi: 10.1007/BF00297369.
10
Crystal agglomeration is a major element in calcium oxalate urinary stone formation.晶体聚集是草酸钙尿路结石形成的一个主要因素。
Kidney Int. 1990 Jan;37(1):51-6. doi: 10.1038/ki.1990.7.

引用本文的文献

1
A metabolic readout of the urine metabolome of COVID-19 patients.新型冠状病毒肺炎患者尿液代谢组学的代谢分析。
Metabolomics. 2023 Jan 24;19(2):7. doi: 10.1007/s11306-023-01971-6.
2
Hydroxycitrate: a potential new therapy for calcium urolithiasis.羟基柠檬酸:治疗钙结石的一种潜在新疗法。
Urolithiasis. 2019 Aug;47(4):311-320. doi: 10.1007/s00240-019-01125-1. Epub 2019 Mar 26.
3
Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.尿石症:评估、饮食因素和医学管理:2014 年 SIU-ICUD 国际结石病咨询会议的更新。

本文引用的文献

1
Effects of citrate on the different phases of calcium oxalate crystallization.柠檬酸盐对草酸钙结晶不同阶段的影响。
Scanning Microsc. 1993 Mar;7(1):381-9; discussion 389-90.
2
Evaluation of a routine method for determination of calcium oxalate crystal growth inhibition in diluted urine samples.评估一种用于测定稀释尿液样本中草酸钙晶体生长抑制的常规方法。
Clin Chem. 1981 Apr;27(4):565-8.
3
Long-term treatment of calcium nephrolithiasis with potassium citrate.枸橼酸钾对钙结石症的长期治疗
World J Urol. 2017 Sep;35(9):1331-1340. doi: 10.1007/s00345-017-2000-1. Epub 2017 Feb 3.
4
Calcium renal lithiasis: metabolic diagnosis and medical treatment.肾钙质结石:代谢诊断与内科治疗
Sao Paulo Med J. 2013;131(1):46-53. doi: 10.1590/s1516-31802013000100008.
5
Oxalate synthesis from hydroxypyruvate in vitamin-B6-deficient rats.维生素B6缺乏大鼠中由羟基丙酮酸合成草酸盐的过程。
Urol Res. 2007 Aug;35(4):173-8. doi: 10.1007/s00240-007-0102-8. Epub 2007 Jun 13.
6
Concentrated urine and diluted urine: the effects of citrate and magnesium on the crystallization of calcium oxalate induced in vitro by an oxalate load.浓缩尿与稀释尿:柠檬酸盐和镁对草酸盐负荷体外诱导草酸钙结晶的影响
Urol Res. 2006 Dec;34(6):359-64. doi: 10.1007/s00240-006-0067-z.
7
Oxalate and its handling in a low stone risk vs a stone-prone population group.
World J Urol. 2005 Nov;23(5):330-3. doi: 10.1007/s00345-005-0030-6. Epub 2005 Nov 6.
8
Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.柠檬酸钠制剂在草酸钙尿路结石管理中的预防和治疗特性:随机、安慰剂对照试验
Urol Res. 2005 May;33(2):116-24. doi: 10.1007/s00240-005-0466-6. Epub 2005 May 4.
9
Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?在高浓度尿液中,柠檬酸盐是草酸钙晶体生长的抑制剂吗?
Urol Res. 1996;24(2):67-71. doi: 10.1007/BF00431081.
J Urol. 1985 Jul;134(1):11-9. doi: 10.1016/s0022-5347(17)46962-x.
4
A urinary calcium-citrate index for the evaluation of nephrolithiasis.
Kidney Int. 1986 Jul;30(1):85-90. doi: 10.1038/ki.1986.155.
5
Rational prevention of calcium urolithiasis.
Urol Int. 1986;41(5):387-92. doi: 10.1159/000281240.
6
The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.胱氨酸肾结石患者的代谢异常谱。
J Urol. 1989 Apr;141(4):819-21. doi: 10.1016/s0022-5347(17)41019-6.
7
Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.尿蛋白对一水合草酸钙晶体聚集的抑制作用。
Am J Physiol. 1989 Jul;257(1 Pt 2):F99-106. doi: 10.1152/ajprenal.1989.257.1.F99.
8
Crystal agglomeration is a major element in calcium oxalate urinary stone formation.晶体聚集是草酸钙尿路结石形成的一个主要因素。
Kidney Int. 1990 Jan;37(1):51-6. doi: 10.1038/ki.1990.7.
9
Protein inhibitors of crystallization.
Semin Nephrol. 1991 Mar;11(2):98-109.
10
Citrate and renal calculi: new insights and future directions.柠檬酸盐与肾结石:新见解与未来方向
Am J Kidney Dis. 1991 Apr;17(4):420-5. doi: 10.1016/s0272-6386(12)80635-4.